AECOPD | ||||||
---|---|---|---|---|---|---|
CH without GR and TI | GR | |||||
Time period | Cases | Inhabitants | Incidence (/100 000) | Cases | Inhabitants | Incidence (/100 000) |
March 2003–February 2004 | 4437 | 6.867.802 | 65 | 184 | 187.088 | 98 |
March 2004–February 2005 | 4636 | 6.914.307 | 67 | 173 | 187.811 | 92 |
March 2005–February 2006 | 4841 | 6.956.869 | 70 | 193 | 187.822 | 103 |
March 2006–February 2007 | 5401 | 7.009.332 | 77 | 218 | 188.060 | 116 |
March 2007–February 2008 | 5350 | 7.093.237 | 75 | 178 | 189.045 | 94 |
March 2008–February 2009 | 5077 | 7.191.922 | 71 | 172 | 190.693 | 90 |
March 2009–February 2010 | 4435 | 7.272.481 | 61 | 127 | 191.988 | 66 |
IRR (before vs after ban) | 0.93 (0.91 to 0.95) | 0.78 (0.68 to 0.88) | ||||
p | <0.001 | <0.001 | ||||
p CH versus GR | 0.008 |
The time periods after introduction of the ban are highlighted in bold.
AECOPD, acute exacerbated chronic obstructive pulmonary disease; IRR, incidence rate ratio.